Literature DB >> 24626431

Should rituximab be used to prevent relapse in patients with ANCA-associated vasculitis?

Stephen P McAdoo1, Charles D Pusey.   

Abstract

Entities:  

Keywords:  ANCA; lymphocytes; vasculitis

Mesh：

Substances：

Year:  2014        PMID： 24626431      PMCID： PMC3974343          DOI： 10.2215/CJN.01270214

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  27 in total

1.  Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.

Authors:  Rachel B Jones; Jan Willem Cohen Tervaert; Thomas Hauser; Raashid Luqmani; Matthew D Morgan; Chen Au Peh; Caroline O Savage; Mårten Segelmark; Vladimir Tesar; Pieter van Paassen; Dorothy Walsh; Michael Walsh; Kerstin Westman; David R W Jayne
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

2.  The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging.

Authors:  Fabricio Montalvao; Zacarias Garcia; Susanna Celli; Béatrice Breart; Jacques Deguine; Nico Van Rooijen; Philippe Bousso
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

3.  EULAR recommendations for the management of primary small and medium vessel vasculitis.

Authors:  C Mukhtyar; L Guillevin; M C Cid; B Dasgupta; K de Groot; W Gross; T Hauser; B Hellmich; D Jayne; C G M Kallenberg; P A Merkel; H Raspe; C Salvarani; D G I Scott; C Stegeman; R Watts; K Westman; J Witter; H Yazici; R Luqmani
Journal:  Ann Rheum Dis       Date:  2008-04-15       Impact factor: 19.103

4.  Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.

Authors:  Mary-Jane C J Guerry; Paul Brogan; Ian N Bruce; David P D'Cruz; Lorraine Harper; Raashid Luqmani; Charles D Pusey; Alan D Salama; David G I Scott; Caroline O S Savage; Richard A Watts; David R W Jayne
Journal:  Rheumatology (Oxford)       Date:  2011-05-25       Impact factor: 7.580

5.  Decreased CD5⁺ B cells in active ANCA vasculitis and relapse after rituximab.

Authors:  Donna O'Dell Bunch; JulieAnne G McGregor; Nirmal B Khandoobhai; Lydia T Aybar; Madelyn E Burkart; Yichun Hu; Susan L Hogan; Caroline J Poulton; Elisabeth A Berg; Ronald J Falk; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-04       Impact factor: 8.237

6.  Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.

Authors:  Lorraine Harper; Matthew D Morgan; Michael Walsh; Peter Hoglund; Kerstin Westman; Oliver Flossmann; Vladimir Tesar; Phillipe Vanhille; Kirsten de Groot; Raashid Luqmani; Luis Felipe Flores-Suarez; Richard Watts; Charles Pusey; Annette Bruchfeld; Niels Rasmussen; Daniel Blockmans; Caroline O Savage; David Jayne
Journal:  Ann Rheum Dis       Date:  2011-11-29       Impact factor: 19.103

7.  Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Kirsten De Groot; Niels Rasmussen; Paul A Bacon; Jan Willem Cohen Tervaert; Conleth Feighery; Gina Gregorini; Wolfgang L Gross; Raashid Luqmani; David R W Jayne
Journal:  Arthritis Rheum       Date:  2005-08

8.  Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials.

Authors:  Joanna Robson; Helen Doll; Ravi Suppiah; Oliver Flossmann; Lorraine Harper; Peter Höglund; David Jayne; Alfred Mahr; Kerstin Westman; Raashid Luqmani
Journal:  Ann Rheum Dis       Date:  2013-11-15       Impact factor: 19.103

9.  B cell biomarkers of rituximab responses in systemic lupus erythematosus.

Authors:  Edward M Vital; Shouvik Dass; Maya H Buch; Karen Henshaw; Colin T Pease; Michael F Martin; Frederique Ponchel; Andrew C Rawstron; Paul Emery
Journal:  Arthritis Rheum       Date:  2011-10

10.  Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis.

Authors:  Ruth J Pepper; Sally Hamour; Konstantia-Maria Chavele; Sarah K Todd; Niels Rasmussen; Shaun Flint; Paul A Lyons; Kenneth G C Smith; Charles D Pusey; H Terence Cook; Alan D Salama
Journal:  Kidney Int       Date:  2013-02-20       Impact factor: 10.612
View more
  2 in total

1.  Pauci-Immune Necrotizing and Crescentic Glomerulonephritis with Membranous Lupus Nephritis, Fifteen Years after Initial Diagnosis of Secondary Membranous Nephropathy.

Authors:  Ryan Burkhart; Nina Shah; Michael Abel; James D Oliver; Matthew Lewin
Journal:  Case Rep Nephrol       Date:  2015-10-08

2.  Danger-associated molecular pattern molecules and the receptor for advanced glycation end products enhance ANCA-induced responses.

Authors:  Theresa H Page; Derick Chiappo; Francesca Brunini; Josep Garnica; Jack Blackburn; Fayaz Dudhiya; Maria Prendecki; Stephen P McAdoo; Charles D Pusey
Journal:  Rheumatology (Oxford)       Date:  2022-02-02       Impact factor: 7.580
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.